Lower urinary tract function and urogenital infections

Joint meeting of the EAU Section of Female and Functional Urology (ESFFU) and the EAU Section of Infections in Urology (ESIU)

  • Location:
    Room 14c (ICM, Level 1)
  • Chairs:
     T.E. Bjerklund Johansen, Oslo (NO)
     J.P.F.A. Heesakkers, Nijmegen (NL)
  • Aims and objectives of this session

    This joint ESFFU and ESIU session will provide a comprehensive update on topics common to both specialist sections and offers state of the art presentations in the overlapping fields of functional disorders, reconstructive operations and infective complications.

    Delegates will be given deep insight into basic aspects including the importance of the urine microbiome and the myth that normal urine is sterile. Speakers will address infectious complications related to diversions and reservoirs, catheters and implants. All topics will be addressed by key international experts and opinion leaders and separate moderators will ensure that important questions from the audience are thoroughly discussed and answered. The session is organised in three parts: Basic aspects, functional disorders and reconstruction.

    To complete this joint ESFFU-ESIU session, the delegates will obtain deep insight into recent knowledge about the relationship between function, foreign bodies and infection. He or she will be updated on how to prevent and treat urological infections in pregnancy and neurological disorders, as well as complications of all kind of implants and reconstructive surgery in urology.

Welcome and introduction
 T.E. Bjerklund Johansen, Oslo (NO)
Session I: Basic aspects
 D.M. Castro Díaz, La Laguna Santa Cruz Tenerife (ES)
 F.M.E. Wagenlehner, Gießen (DE)
Who is to blame in UTI, the host, the microorganisms or both?
 B. Wullt, Lund (SE)
The role of the microbiome in the development of urinary tract problems
 V. Smelov, Lyon (FR)
The role of brush cells in the urinary tract and the development of UTI
 W. Kummer, Giessen (DE)
Is UTI in a neurogenic patient different from UTI in a non-neurogenic patient and should it be treated differently?
 M.J. Drake, Bristol (GB)
Session II: Functional disorders and infection
 M. Porena, Perugia (IT)
 P. Tenke, Budapest (HU)
Is OAB an UTI?
 Z. Tandoğdu, Newcastle Upon Tyne (GB)
How to treat urinary tract infections in pregnancy?
 T. Cai, Trento (IT)
Does UTI worsen neurological diseases like MS?
 R. Hamid, London (GB)
Catheters and UTI: Indwelling, intermittent or reusable?
 B. Köves, Budapest (HU)
Prevention and treatment of infective complications of diversions and reservoirs
 J. Bjerggaard Jensen, Århus N (DK)
Session III: Reconstructive urology and infection
 R. Bartoletti, Pistoia (IT)
 S. Charalampous, Limassol (CY)
Is infection the only cause of erosion in urological implants?
 F. Bruyere, Tours (FR)
Prevention and treatment of infective complications of implants for SUI and pelvic organ prolapse
 F. Van Der Aa, Leuven (BE)
Prevention and treatment of infections related to AUS and other male incontinence devices
 K-D. Sievert, Salzburg (AT)
Prevention and treatment of infections related to penile implants
 K-D. Sievert, Salzburg (AT)
How much time is needed before we can re-implant safely without risk of a new infection?
 E. Chartier-Kastler, Paris (FR)
Discussion and closure
 J.P.F.A. Heesakkers, Nijmegen (NL)